Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Equity: 2010-2019

Historic Return on Equity for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2019 value amounting to 0.07%.

  • Neurocrine Biosciences' Return on Equity fell 8.00% to 0.03% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.03%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of 0.07% for FY2019, which is 2.00% up from last year.
  • As of FY2019, Neurocrine Biosciences' Return on Equity stood at 0.07%, which was up 33.79% from 0.05% recorded in FY2018.
  • Neurocrine Biosciences' Return on Equity's 5-year high stood at 0.07% during FY2019, with a 5-year trough of -0.41% in FY2017.
  • Moreover, its 3-year median value for Return on Equity was 0.05% (2018), whereas its average is -0.10%.
  • Per our database at Business Quant, Neurocrine Biosciences' Return on Equity fell by 9bps in 2016 and then skyrocketed by 46bps in 2018.
  • Neurocrine Biosciences' Return on Equity (Yearly) stood at -0.29% in 2015, then fell by 9bps to -0.38% in 2016, then decreased by 3bps to -0.41% in 2017, then surged by 46bps to 0.05% in 2018, then grew by 2bps to 0.07% in 2019.